Condition: Lung Cancer · Surgery · Blood Pressure Management · Sponsor: Peking University First Hospital
Surgery is the front-line therapy for non-small cell lung cancer (NSCLC) but postoperative complications remains high and patients' long-term outcome is still challenging. In addition to surgery, anesthetic management particularly intraoperative blood pressure management and use of dexamethasone may affect patients' early and long-term outcomes after surgery for NSCLC. This study aims to investigate the impact of intraoperative blood pressure management and dexamethasone administration on early and long-term outcomes in patients undergoing surgery for lung cancer.
This description comes directly from the study's public registry record.
Dong-Xin Wang, MD, PhD · 86 (10) 83572784 · wangdongxin@hotmail.com
Wen-Wen Huang, MD · 86 (10) 83572460 · hww9215@163.com
Always discuss trial participation with your own doctor first.
| Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04209218